Inventor · disambiguated record
Wen-Chen Yeh
Also filed as: YEH WEN-CHEN
20 granted patents·14 pending applications·99 citations·filing 2012–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0497US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0597US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0691US12240876B2Liver-specific Wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2023·Granted Mar 4, 2025·1 cites·10 claims
- 0789US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 0886US12006368B2Anti-frizzled antibodies and methods of useSURROZEN OPERATING INC·Filed 2018·Granted Jun 11, 2024·3 cites·8 claims
- 0982US10752664B2Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15)XIONG YUMEI·Filed 2012·Granted Aug 25, 2020·4 cites·11 claims
- 1080US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 1178US12297278B2Wnt surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2023·Granted May 13, 2025·0 cites·5 claims
- 1278US11958891B2Tissue-specific Wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2018·Granted Apr 16, 2024·2 cites·14 claims
- 1377US11746150B2Anti-LRP5/6 antibodies and methods of useSURROZEN OPERATING INC·Filed 2018·Granted Sep 5, 2023·1 cites·10 claims
- 1475US11773171B2WNT surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2018·Granted Oct 3, 2023·1 cites·10 claims
- 1574US10906890B2Triazole phenyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Feb 2, 2021·1 cites·20 claims
- 1673US11020395B2Cycloalkyl substituted triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 1, 2021·1 cites·26 claims
- 1773US2024279303A1Tissue-specific wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2024·Application pending·0 cites
- 1872US2024368287A1Anti-frizzled antibodies and methods of useSURROZEN OPERATING INC·Filed 2024·Application pending·0 cites
- 1970US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 2070US2024150458A1Anti-lrp5/6 antibodies and methods of useSURROZEN OPERATING INC·Filed 2023·Application pending·0 cites
- 2169US2025223368A1Wnt surrogate molecules and uses thereofSURROZEN OPERATING INC·Filed 2025·Application pending·0 cites
- 2266US2025313616A1Modulation of wnt signalling in ocular disordersSURROZEN OPERATING INC·Filed 2025·Application pending·0 cites
- 2362US2025051459A1Wnt-surrogate agents and methods for lacrimal gland regenerationSURROZEN OPERATING INC·Filed 2022·Application pending·0 cites
- 2462US2023295347A1Wnt receptor-specific compound and method relating theretoSURROZEN OPERATING INC·Filed 2022·Application pending·0 cites
- 2560US2020325200A1Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)AMGEN INC·Filed 2020·Application pending·0 cites
- 2659US2025171509A1Liver-specific wnt signal enhancing molecules and uses thereofSURROZEN OPERATING INC·Filed 2025·Application pending·0 cites
- 2758US2024150473A1Modulation of wnt signaling in gastrointestinal disordersSURROZEN OPERATING INC·Filed 2022·Application pending·0 cites
- 2858US2022112278A1Modulation of wnt signalling in ocular disordersSURROZEN INC·Filed 2020·Application pending·0 cites
- 2954US2024391991A1Modulation of wnt signalling in pulmonary disordersSURROZEN OPERATING INC·Filed 2022·Application pending·0 cites
- 3051US2022175884A1Modulation of wnt signaling in auditory disordersSURROZEN OPERATING INC·Filed 2020·Application pending·0 cites
- 3150US9850297B2Secreted frizzle-related protein 5 (SFRP5) binding proteinsAMGEN INC·Filed 2014·Granted Dec 26, 2017·0 cites·11 claims
- 3248US12466884B2Tissue-specific WNT signal enhancing molecules and usesSURROZEN OPERATING INC·Filed 2019·Granted Nov 11, 2025·0 cites·11 claims
- 3347US11191762B2Alkyl substituted triazole compounds as agonists of the APJ ReceptorAMGEN INC·Filed 2017·Granted Dec 7, 2021·0 cites·28 claims
- 3445US2022195053A1Modulation of wnt signaling in gastrointestinal disordersSURROZEN OPERATING INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wen-Chen Yeh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →